{"gene":"ASPA","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1987,"finding":"Aspartoacylase (ASPA) deficiency was identified as the cause of elevated N-acetylaspartate (NAA) excretion and leukodystrophy; fibroblasts from the patient showed absent aspartoacylase activity, establishing that ASPA catalyzes NAA hydrolysis in brain and that its deficiency leads to dysmyelination.","method":"Enzymatic activity assay in patient fibroblasts; CSF/plasma NAA ratio measurement","journal":"Journal of inherited metabolic disease","confidence":"High","confidence_rationale":"Tier 2 — direct enzyme activity measurement in patient cells linking ASPA deficiency to NAA accumulation and disease, foundational finding replicated across subsequent studies","pmids":["3116332"],"is_preprint":false},{"year":1993,"finding":"The human aspartoacylase (ASPA) cDNA was cloned and shown to express aspartoacylase activity in bacteria. A common missense mutation Glu285Ala (854A→C) was identified in 85% of Canavan alleles and predicted to disrupt a catalytic Ser/His/Glu triad, establishing that the catalytic domain involves these residues.","method":"cDNA cloning, heterologous expression in bacteria, mutation analysis of patient alleles","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — direct heterologous expression demonstrating enzymatic activity; foundational cloning paper replicated in many subsequent studies","pmids":["8252036"],"is_preprint":false},{"year":1994,"finding":"The human ASPA gene was mapped to chromosome 17p13-ter, spans 29 kb with 6 exons and 5 introns, and its coding sequences cross-hybridize with genomic DNA from multiple vertebrates, indicating evolutionary conservation of aspartoacylase.","method":"Genomic cloning, Southern blot analysis of somatic cell hybrid lines, fluorescence in situ hybridization (FISH)","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — direct chromosomal localization by FISH and hybrid cell lines; replicated and consistent with subsequent studies","pmids":["8088831"],"is_preprint":false},{"year":1994,"finding":"Three point mutations in ASPA (693C→A causing Tyr231→stop, 854A→C causing Glu285→Ala, 914C→A causing Ala305→Glu) were characterized by in vitro expression: Tyr231→stop and Ala305→Glu cause complete loss of ASPA activity, while Glu285→Ala retains ~2.5% activity. A splice-site mutation (433−2 A→G) causing exon 3 skipping and frameshift was also identified.","method":"In vitro expression of mutant cDNAs in cell-free or cellular systems, enzyme activity assay","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro expression with quantitative activity assay; multiple mutations characterized; widely replicated","pmids":["8023850"],"is_preprint":false},{"year":1995,"finding":"Nine ASPA mutations in non-Jewish Canavan patients were identified; A305E is the predominant pan-European mutation (39.5% of alleles), and in vitro expression studies confirmed these mutations cause loss of aspartoacylase enzymatic activity.","method":"Mutation analysis of ASPA gene, in vitro expression, enzyme activity assay","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro expression with activity assays confirming loss-of-function; broad ethnic characterization","pmids":["7668285"],"is_preprint":false},{"year":1996,"finding":"Eight novel ASPA missense and deletion mutations in non-Jewish Canavan patients (including I16T, G27R, D114E, G123E, C152Y, R168C, 32ΔT, 876ΔAGAA) were introduced into wild-type cDNA by PCR mutagenesis; in vitro expression in COS-7 cells confirmed all lead to ASPA enzyme deficiency.","method":"Site-directed mutagenesis, transient expression in COS-7 cells, enzyme activity assay","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 — direct mutagenesis and expression with quantitative activity measurement","pmids":["8659549"],"is_preprint":false},{"year":1997,"finding":"Analysis of NAA biochemistry in Canavan disease established that ASPA deficiency creates a daily aspartate deficit in the CNS at least six times the static free-aspartate level, eliminates the intercompartmental NAA-to-aspartate cycling that normally supplies acetyl groups for myelin lipid synthesis, and results in up to 50-fold reduction in the intercompartmental NAA gradient.","method":"Biochemical flux analysis of NAA cycle across multiple vertebrate species and Canavan disease metabolite data","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative metabolic modeling grounded in multi-species biochemical data; single lab but uses multiple data sources","pmids":["9407392"],"is_preprint":false},{"year":2002,"finding":"Fourteen novel ASPA mutations in non-Jewish patients were identified; in vitro expression in COS-7 cells and patient fibroblast assays confirmed enzyme deficiency. Notably, E24G disrupts the first esterase catalytic domain consensus sequence, reinforcing the importance of Glu24 for catalysis; IVS1−2A→T caused retention of 40 nt of intron 1.","method":"ASPA gene sequencing, transient expression in COS-7 cells, enzyme activity assay in fibroblasts","journal":"Journal of inherited metabolic disease","confidence":"High","confidence_rationale":"Tier 1 — direct expression and activity assay confirming pathogenicity; multiple mutations across diverse patients","pmids":["12638939"],"is_preprint":false},{"year":2002,"finding":"AAV-2 vector-mediated delivery of the ASPA gene directly to human brain in Canavan disease patients demonstrated the first clinical use of AAV in the human brain, providing proof-of-concept that ASPA can be delivered in vivo to correct the enzymatic deficiency.","method":"Clinical gene therapy protocol; neurosurgical AAV-2 delivery; pre/post neurological, biochemical, and radiological assessment","journal":"Human gene therapy","confidence":"Medium","confidence_rationale":"Tier 2 — first-in-human interventional study; single trial, pilot scale","pmids":["12162821"],"is_preprint":false},{"year":2003,"finding":"Murine and human aspartoacylase were cloned and expressed in E. coli. Kinetic parameters showed relaxed substrate specificity for the acyl group. The clinically relevant E285A mutant has markedly reduced stability and barely detectable activity, while E285D retains ~one-fifth normal activity, establishing that Glu285 is critical for catalysis.","method":"Recombinant expression in E. coli, enzyme-coupled continuous spectrophotometric kinetic assay, site-directed mutagenesis","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with quantitative kinetics and mutagenesis","pmids":["12706335"],"is_preprint":false},{"year":2006,"finding":"Crystal structures of human (2.8 Å) and rat (1.8 Å) aspartoacylase revealed that the N-terminal domain adopts a zinc-dependent hydrolase fold related to carboxypeptidase A, with a catalytic zinc ion coordinated by specific residues. The C-terminal domain (~100 residues) forms a globular domain that wraps around the N-terminal domain and occludes the active-site channel from polypeptide substrates. Residues 158–164 may gate substrate access. The catalytic mechanism is proposed to be analogous to carboxypeptidases.","method":"X-ray crystallography of recombinant human and rat ASPA; structural comparison with carboxypeptidase A","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional interpretation; two species solved independently","pmids":["17194761"],"is_preprint":false},{"year":2006,"finding":"Human aspartoacylase expressed in Pichia pastoris is 150-fold more active and significantly more stable than the E. coli-expressed form. Mass spectrometry showed the enzyme contains a glycosylation modification; deglycosylation or mutation at the glycosylation site decreases stability and catalytic activity. Each subunit contains one zinc atom; chelation causes reversible loss of activity, establishing ASPA as a zinc metalloenzyme.","method":"Pichia pastoris expression, mass spectrometry of glycan, zinc chelation studies, kinetic assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution, zinc chelation reversal, glycosylation mutagenesis; multiple orthogonal methods in one study","pmids":["16669630"],"is_preprint":false},{"year":2006,"finding":"Aspartoacylase localizes not only to the cytoplasm but also to the nucleus of rat brain cells, kidney, and cultured oligodendrocytes. Subcellular fractionation showed low but detectable NAA-hydrolyzing activity in nuclear fractions. Size-exclusion chromatography showed ASPA is an active monomer in both compartments (not a dimer). A GFP-hASPA fusion protein exceeding the nuclear pore size limit also showed nuclear distribution, suggesting active or facilitated nuclear import.","method":"Immunohistochemistry, subcellular fractionation with enzyme activity assay, size-exclusion chromatography, GFP fusion protein expression in COS-7 cells","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization methods with functional (enzymatic) validation in both compartments","pmids":["16935940"],"is_preprint":false},{"year":2007,"finding":"Homology modeling of ASPA based on carboxypeptidase A guided site-directed mutagenesis. Mutations of putative zinc-binding residues (H21G, E24D/G, H116G), the proposed proton donor (E178A), substrate carboxyl-binding residue (R71N), and transition-state stabilizing residue (R63N) all yield wild-type ASPA protein levels but undetectable activity. Double-swap mutants (H21E/E24H and E24H/H116E) also abolish activity. Cys124 and Cys152 alanine substitutions reduce both protein and activity levels, suggesting a disulfide bond. These results confirm ASPA belongs to the carboxypeptidase A family and define key catalytic residues.","method":"Homology modeling, site-directed mutagenesis, transient expression, Western blotting, enzyme activity assay","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis of multiple active-site residues with quantitative activity and protein-level controls","pmids":["17391648"],"is_preprint":false}],"current_model":"ASPA (aspartoacylase) is a zinc metalloenzyme with a carboxypeptidase A-like N-terminal catalytic domain and a C-terminal domain that gates substrate access; it hydrolyzes N-acetyl-L-aspartate (NAA) to aspartate and acetate in the brain, is glycosylated (glycosylation required for stability and activity), functions as an active monomer in both cytoplasmic and nuclear compartments of oligodendrocytes, and loss-of-function mutations abolishing activity at zinc-coordinating (H21, E24, H116), proton-donor (E178), or substrate-binding (R63, R71) residues cause Canavan disease through NAA accumulation and failure of acetyl-group supply for myelin lipid synthesis."},"narrative":{"teleology":[{"year":1987,"claim":"Identifying the enzymatic basis of Canavan disease established that ASPA catalyzes NAA hydrolysis and that its deficiency leads to NAA accumulation and dysmyelination, framing the gene's central biological role.","evidence":"Enzymatic activity assay in patient fibroblasts showing absent aspartoacylase activity","pmids":["3116332"],"confidence":"High","gaps":["Molecular identity (gene/cDNA) of ASPA not yet determined","Catalytic mechanism unknown","Tissue and subcellular distribution of activity uncharacterized"]},{"year":1993,"claim":"Cloning the ASPA cDNA and demonstrating recombinant enzymatic activity enabled molecular characterization of disease-causing mutations and first implicated specific residues (including E285) in catalysis.","evidence":"cDNA cloning with heterologous expression in bacteria; identification of E285A as the predominant Ashkenazi Jewish mutation","pmids":["8252036"],"confidence":"High","gaps":["Catalytic mechanism and active-site architecture unresolved","Three-dimensional structure unavailable"]},{"year":1994,"claim":"Systematic in vitro expression of patient-derived mutations (Y231X, E285A, A305E) quantified residual activity and demonstrated allelic heterogeneity, while genomic characterization mapped ASPA to 17p13-ter across six exons.","evidence":"In vitro mutagenesis and expression with quantitative enzyme assays; FISH and somatic cell hybrid mapping","pmids":["8023850","8088831"],"confidence":"High","gaps":["Structure-function relationships for most residues unknown","No structural data to explain why specific mutations abolish activity"]},{"year":1996,"claim":"Expanding the mutation spectrum across diverse ethnic backgrounds (including I16T, G27R, D114E, G123E, C152Y, R168C) and confirming loss of function by COS-7 expression demonstrated that pathogenic variants are distributed across the entire protein, not confined to a single domain.","evidence":"Site-directed mutagenesis with transient expression in COS-7 cells and enzyme activity assay","pmids":["8659549","7668285","12638939"],"confidence":"High","gaps":["Active-site residue identity still inferred from sequence homology rather than structure","Role of glycosylation and metal cofactors unknown"]},{"year":1997,"claim":"Metabolic flux analysis revealed that ASPA deficiency eliminates intercompartmental NAA-to-aspartate cycling, creating a large daily aspartate deficit and depriving oligodendrocytes of acetyl groups for myelin lipid synthesis — connecting the enzymatic defect to the dysmyelination phenotype.","evidence":"Quantitative biochemical flux modeling using multi-species NAA metabolite data and Canavan disease metabolite profiles","pmids":["9407392"],"confidence":"Medium","gaps":["Flux estimates rely on modeling rather than direct in vivo tracing","Relative contribution of acetyl-group deficit vs. NAA toxicity to pathology not resolved"]},{"year":2003,"claim":"Recombinant kinetic characterization showed relaxed acyl-group specificity and confirmed that E285A drastically reduces both stability and activity while the conservative E285D retains partial function, pinpointing E285 as catalytically essential.","evidence":"Recombinant E. coli expression with continuous spectrophotometric kinetic assays and site-directed mutagenesis","pmids":["12706335"],"confidence":"High","gaps":["Structural basis of E285 contribution awaited crystallographic data","Substrate-binding mode unresolved"]},{"year":2006,"claim":"Crystal structures of human and rat ASPA revealed a two-domain architecture — an N-terminal carboxypeptidase A-like zinc hydrolase domain and a C-terminal domain that occludes the active site from polypeptide substrates — explaining the enzyme's specificity for small-molecule NAA and identifying the zinc coordination sphere and a putative substrate-gating loop (residues 158–164).","evidence":"X-ray crystallography at 2.8 Å (human) and 1.8 Å (rat) resolution","pmids":["17194761"],"confidence":"High","gaps":["No substrate- or product-bound co-crystal structure","Gating dynamics of residues 158–164 not experimentally validated"]},{"year":2006,"claim":"Demonstrating that ASPA is glycosylated, contains one zinc per subunit with chelation-reversible activity loss, and functions as a monomer in both cytoplasm and nucleus of oligodendrocytes established key biochemical properties and an unexpected nuclear localization with enzymatic activity.","evidence":"Pichia pastoris expression with mass spectrometry (glycan), zinc chelation/reconstitution, subcellular fractionation with activity assay, size-exclusion chromatography, GFP-fusion localization in COS-7 cells","pmids":["16669630","16935940"],"confidence":"High","gaps":["Nuclear import mechanism (signal sequence or carrier) not identified","Biological role of nuclear NAA hydrolysis unknown"]},{"year":2007,"claim":"Comprehensive site-directed mutagenesis of predicted active-site residues (H21, E24, H116 for zinc coordination; E178 as proton donor; R63, R71 for substrate binding; C124/C152 for disulfide stability) definitively assigned catalytic roles, confirming ASPA belongs to the carboxypeptidase A metalloenzyme family.","evidence":"Homology model-guided mutagenesis with transient expression, Western blot protein-level controls, and quantitative enzyme activity assay","pmids":["17391648"],"confidence":"High","gaps":["No substrate-bound crystal structure to confirm predicted binding geometry","Transition-state stabilization by R63 inferred from analogy, not directly visualized"]},{"year":null,"claim":"The biological function of nuclear ASPA, the structural basis of substrate gating by the C-terminal domain, and the relative contributions of NAA toxicity versus acetyl-group deprivation to Canavan disease pathogenesis remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No substrate- or transition-state-bound co-crystal structure available","Nuclear import mechanism and nuclear NAA metabolic function uncharacterized","In vivo metabolic tracing to distinguish NAA toxicity from acetyl-group deficit not performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,9,10,11,13]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[12]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[12]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,6,9]}],"complexes":[],"partners":[],"other_free_text":[]},"mechanistic_narrative":"ASPA (aspartoacylase) is a zinc metalloenzyme that hydrolyzes N-acetyl-L-aspartate (NAA) to aspartate and acetate, providing acetyl groups essential for myelin lipid synthesis in the central nervous system [PMID:3116332, PMID:9407392]. Structurally, ASPA comprises an N-terminal catalytic domain with a carboxypeptidase A-like zinc-dependent hydrolase fold and a C-terminal domain that gates substrate access to the active site; catalysis depends on zinc-coordinating residues (H21, E24, H116), a proton donor (E178), and substrate-binding arginines (R63, R71), and glycosylation is required for full stability and activity [PMID:17194761, PMID:17391648, PMID:16669630]. ASPA functions as an active monomer in both the cytoplasm and nucleus of oligodendrocytes, with evidence for active or facilitated nuclear import [PMID:16935940]. Loss-of-function mutations in ASPA cause Canavan disease, an autosomal recessive leukodystrophy characterized by NAA accumulation and dysmyelination [PMID:3116332, PMID:8252036]."},"prefetch_data":{"uniprot":{"accession":"P45381","full_name":"Aspartoacylase","aliases":["Aminoacylase-2","ACY-2"],"length_aa":313,"mass_kda":35.7,"function":"Catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P45381/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ASPA","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ASPA","total_profiled":1310},"omim":[{"mim_id":"614372","title":"MANNOSE-BINDING LECTIN DEFICIENCY; MBLD","url":"https://www.omim.org/entry/614372"},{"mim_id":"608034","title":"ASPARTOACYLASE; ASPA","url":"https://www.omim.org/entry/608034"},{"mim_id":"606411","title":"SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER), MEMBER 3; SLC13A3","url":"https://www.omim.org/entry/606411"},{"mim_id":"271900","title":"CANAVAN DISEASE","url":"https://www.omim.org/entry/271900"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":30.0},{"tissue":"kidney","ntpm":35.6}],"url":"https://www.proteinatlas.org/search/ASPA"},"hgnc":{"alias_symbol":["ASP","ACY2"],"prev_symbol":[]},"alphafold":{"accession":"P45381","domains":[{"cath_id":"3.40.630.10","chopping":"5-221_303-309","consensus_level":"high","plddt":96.7906,"start":5,"end":309}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P45381","model_url":"https://alphafold.ebi.ac.uk/files/AF-P45381-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P45381-F1-predicted_aligned_error_v6.png","plddt_mean":96.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ASPA","jax_strain_url":"https://www.jax.org/strain/search?query=ASPA"},"sequence":{"accession":"P45381","fasta_url":"https://rest.uniprot.org/uniprotkb/P45381.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P45381/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P45381"}},"corpus_meta":[{"pmid":"10656250","id":"PMC_10656250","title":"Identification of a novel aspartic protease (Asp 2) as beta-secretase.","date":"1999","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/10656250","citation_count":938,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2848850","id":"PMC_2848850","title":"Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.","date":"1988","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2848850","citation_count":450,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18824507","id":"PMC_18824507","title":"Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration.","date":"2008","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/18824507","citation_count":241,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1537377","id":"PMC_1537377","title":"Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen.","date":"1992","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1537377","citation_count":212,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12162821","id":"PMC_12162821","title":"Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.","date":"2002","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/12162821","citation_count":193,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9538242","id":"PMC_9538242","title":"His-Asp phosphotransfer signal transduction.","date":"1998","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9538242","citation_count":174,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7757071","id":"PMC_7757071","title":"Structure and function of ASP, the human homolog of the mouse agouti gene.","date":"1995","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7757071","citation_count":159,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10562565","id":"PMC_10562565","title":"Synthesis of aspartyl-tRNA(Asp) in Escherichia coli--a snapshot of the second step.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10562565","citation_count":154,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10073938","id":"PMC_10073938","title":"Abnormal spindle protein, Asp, and the integrity of mitotic centrosomal microtubule organizing centers.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10073938","citation_count":141,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18567810","id":"PMC_18567810","title":"Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like catalytic mechanism.","date":"2008","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18567810","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11352927","id":"PMC_11352927","title":"The drosophila protein asp is involved in microtubule organization during spindle formation and cytokinesis.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11352927","citation_count":131,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15796531","id":"PMC_15796531","title":"RNA SHAPE chemistry reveals nonhierarchical interactions dominate equilibrium structural transitions in tRNA(Asp) transcripts.","date":"2005","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/15796531","citation_count":131,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9555951","id":"PMC_9555951","title":"Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period.","date":"1998","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/9555951","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11283617","id":"PMC_11283617","title":"Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes.","date":"2001","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11283617","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10930573","id":"PMC_10930573","title":"Possible His to Asp phosphorelay signaling in an Arabidopsis two-component system.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10930573","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1988465","id":"PMC_1988465","title":"An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1988465","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8406453","id":"PMC_8406453","title":"A homoallelic Gly317-->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8406453","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10355026","id":"PMC_10355026","title":"Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.","date":"1999","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10355026","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12244109","id":"PMC_12244109","title":"Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12244109","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15888542","id":"PMC_15888542","title":"Spindle pole organization in Drosophila S2 cells by dynein, abnormal spindle protein (Asp), and KLP10A.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15888542","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24142104","id":"PMC_24142104","title":"The microcephaly protein Asp regulates neuroepithelium morphogenesis by controlling the spatial distribution of myosin II.","date":"2013","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24142104","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1629196","id":"PMC_1629196","title":"The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania mimics the Arg-Gly-Asp-Ser cell attachment region of fibronectin.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1629196","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9059512","id":"PMC_9059512","title":"Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line.","date":"1997","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9059512","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9636030","id":"PMC_9636030","title":"His...Asp catalytic dyad of ribonuclease A: structure and function of the wild-type, D121N, and D121A enzymes.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9636030","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25602029","id":"PMC_25602029","title":"A tonoplast Glu/Asp/GABA exchanger that affects tomato fruit amino acid composition.","date":"2015","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25602029","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11494148","id":"PMC_11494148","title":"STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity.","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11494148","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10593909","id":"PMC_10593909","title":"Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10593909","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19949047","id":"PMC_19949047","title":"Septins AspA and AspC are important for normal development and limit the emergence of new growth foci in the multicellular fungus Aspergillus nidulans.","date":"2009","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/19949047","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10484614","id":"PMC_10484614","title":"Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance.","date":"1999","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/10484614","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1699202","id":"PMC_1699202","title":"Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1699202","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22326821","id":"PMC_22326821","title":"Anti-diabetic activities of Acanthopanax senticosus polysaccharide (ASP) in combination with metformin.","date":"2012","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/22326821","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10823823","id":"PMC_10823823","title":"Cleavage of the actin-capping protein alpha -adducin at Asp-Asp-Ser-Asp633-Ala by caspase-3 is preceded by its phosphorylation on serine 726 in cisplatin-induced apoptosis of renal epithelial cells.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10823823","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17083466","id":"PMC_17083466","title":"Identification of an essential gene responsible for D-Asp incorporation in the Lactococcus lactis peptidoglycan crossbridge.","date":"2006","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17083466","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1656452","id":"PMC_1656452","title":"Locations of Arg-82, Asp-85, and Asp-96 in helix C of bacteriorhodopsin relative to the aqueous boundaries.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1656452","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8845758","id":"PMC_8845758","title":"Roles of Glu 349 and Asp 352 in membrane insertion and translocation by diphtheria toxin.","date":"1996","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/8845758","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11927587","id":"PMC_11927587","title":"Catalytic mechanism of S-adenosylhomocysteine hydrolase. Site-directed mutagenesis of Asp-130, Lys-185, Asp-189, and Asn-190.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11927587","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8385140","id":"PMC_8385140","title":"Antiapoptotic effect of heterozygously expressed mutant RI (Ala336-->Asp) subunit of cAMP kinase I in a rat leukemia cell line.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8385140","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7765724","id":"PMC_7765724","title":"Site-directed mutagenesis of the Asp-197 and Asp-202 residues in chitinase A1 of Bacillus circulans WL-12.","date":"1994","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7765724","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21736640","id":"PMC_21736640","title":"Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation.","date":"2011","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21736640","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37981824","id":"PMC_37981824","title":"Exploring Kinase Asp-Phe-Gly (DFG) Loop Conformational Stability with AlphaFold2-RAVE.","date":"2023","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/37981824","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19767107","id":"PMC_19767107","title":"Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.","date":"2009","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19767107","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14699067","id":"PMC_14699067","title":"A single amino acid change (Asp 53 --> Ala53) converts Survivin from anti-apoptotic to pro-apoptotic.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/14699067","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17191042","id":"PMC_17191042","title":"C-kit Asp-816-Val mutation analysis in patients with mastocytosis.","date":"2007","source":"Dermatology (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/17191042","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26644514","id":"PMC_26644514","title":"Microcephaly protein Asp focuses the minus ends of spindle microtubules at the pole and within the spindle.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26644514","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25266634","id":"PMC_25266634","title":"Extracellular-matrix-based and Arg-Gly-Asp-modified photopolymerizing hydrogels for cartilage tissue engineering.","date":"2014","source":"Tissue engineering. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/25266634","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10794527","id":"PMC_10794527","title":"His-Asp phosphorelay signaling: a communication avenue between plants and their environment.","date":"2000","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10794527","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15471839","id":"PMC_15471839","title":"Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.","date":"2004","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15471839","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25809376","id":"PMC_25809376","title":"The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection.","date":"2015","source":"Retrovirology","url":"https://pubmed.ncbi.nlm.nih.gov/25809376","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9864052","id":"PMC_9864052","title":"Immunodominant peptide epitopes of allergen, Asp f 1 from the fungus Aspergillus fumigatus.","date":"1998","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/9864052","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7695862","id":"PMC_7695862","title":"The adipsin-ASP pathway and regulation of adipocyte function.","date":"1994","source":"Annals of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7695862","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26620907","id":"PMC_26620907","title":"An Asp-CaM complex is required for centrosome-pole cohesion and centrosome inheritance in neural stem cells.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26620907","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9767372","id":"PMC_9767372","title":"Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.","date":"1998","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9767372","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9833913","id":"PMC_9833913","title":"Inhibition of integrin signaling with Arg-Gly-Asp motifs in rat hepatic stellate cells.","date":"1998","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/9833913","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11331006","id":"PMC_11331006","title":"Involvement of the Arg-Asp-His catalytic triad in enzymatic cleavage of the phosphodiester bond.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11331006","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16164993","id":"PMC_16164993","title":"Glu-Q-tRNA(Asp) synthetase coded by the yadB gene, a new paralog of aminoacyl-tRNA synthetase that glutamylates tRNA(Asp) anticodon.","date":"2005","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/16164993","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23956345","id":"PMC_23956345","title":"Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.","date":"2013","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23956345","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12124386","id":"PMC_12124386","title":"The role of Asp-462 in regulating Akt activity.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12124386","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21832054","id":"PMC_21832054","title":"Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832054","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20437187","id":"PMC_20437187","title":"Influence of Lβ-, Dα- and Dβ-Asp isomers of the Asp-76 residue on the properties of αA-crystallin 70-88 peptide.","date":"2010","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/20437187","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28174730","id":"PMC_28174730","title":"Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice.","date":"2016","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/28174730","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11360154","id":"PMC_11360154","title":"Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents.","date":"2001","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/11360154","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17464341","id":"PMC_17464341","title":"The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance.","date":"2007","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/17464341","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10536308","id":"PMC_10536308","title":"[Cytotoxic activity and cytokine gene induction of Asp-hemolysin to murine macrophages].","date":"1999","source":"Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology","url":"https://pubmed.ncbi.nlm.nih.gov/10536308","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3917033","id":"PMC_3917033","title":"The structure of yeast tRNA(Asp). A model for tRNA interacting with messenger RNA.","date":"1985","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/3917033","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10736481","id":"PMC_10736481","title":"High sensitivity bioassay of paralytic (PSP) and amnesic (ASP) algal toxins based on the fluorimetric detection of [Ca(2+)](i) in rat cortical primary cultures.","date":"2000","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/10736481","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6088667","id":"PMC_6088667","title":"Cloning of the aspartase gene (aspA) of Escherichia coli.","date":"1984","source":"Journal of general microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/6088667","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8968608","id":"PMC_8968608","title":"Perturbed interaction between residues 85 and 204 in Tyr-185-->Phe and Asp-85-->Glu bacteriorhodopsins.","date":"1996","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8968608","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25086295","id":"PMC_25086295","title":"Molecular cloning and functional characterization of porcine DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 (DDX41).","date":"2014","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25086295","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12443689","id":"PMC_12443689","title":"A family of activation associated secreted protein (ASP) homologues of Cooperia punctata.","date":"2002","source":"Research in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/12443689","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26755582","id":"PMC_26755582","title":"A dynamic Asp-Arg interaction is essential for catalysis in microsomal prostaglandin E2 synthase.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26755582","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23280575","id":"PMC_23280575","title":"Isomerization of Asp-Asp motif in model peptides and a monoclonal antibody Fab fragment.","date":"2012","source":"Journal of pharmaceutical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23280575","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26700637","id":"PMC_26700637","title":"Isomerization of Asp residues plays an important role in αA-crystallin dissociation.","date":"2016","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/26700637","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18714034","id":"PMC_18714034","title":"Production of C5a by ASP, a serine protease released from Aeromonas sobria.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18714034","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23638083","id":"PMC_23638083","title":"The AgI/II family adhesin AspA is required for respiratory infection by Streptococcus pyogenes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23638083","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22021175","id":"PMC_22021175","title":"Loss of ASP but not ROPN1 reduces mammalian ciliary motility.","date":"2011","source":"Cytoskeleton (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/22021175","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32087377","id":"PMC_32087377","title":"Venomics of the asp viper Vipera aspis aspis from France.","date":"2020","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/32087377","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6256150","id":"PMC_6256150","title":"des-Asp-angiotensin I: its identification in rat blood and confirmation as a substrate for converting enzyme.","date":"1981","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/6256150","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28545444","id":"PMC_28545444","title":"Site-specific His/Asp phosphoproteomic analysis of prokaryotes reveals putative targets for drug resistance.","date":"2017","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28545444","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30896385","id":"PMC_30896385","title":"Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1).","date":"2019","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/30896385","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31606080","id":"PMC_31606080","title":"Site-specific analysis of the Asp- and Glu-ADP-ribosylated proteome by quantitative mass spectrometry.","date":"2019","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/31606080","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10365751","id":"PMC_10365751","title":"Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys).","date":"1999","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/10365751","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10698341","id":"PMC_10698341","title":"A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.","date":"1999","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10698341","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31591905","id":"PMC_31591905","title":"LPS-induced inflammation delays the transportation of ASP+ due to down-regulation of OCTN1/2 in alveolar epithelial cells.","date":"2019","source":"Journal of drug targeting","url":"https://pubmed.ncbi.nlm.nih.gov/31591905","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2062880","id":"PMC_2062880","title":"Resonance Raman spectra of bacteriorhodopsin mutants with substitutions at Asp-85, Asp-96, and Arg-82.","date":"1991","source":"Photochemistry and photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/2062880","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36291634","id":"PMC_36291634","title":"Deciphering the Alphabet of Disorder-Glu and Asp Act Differently on Local but Not Global Properties.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36291634","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35901362","id":"PMC_35901362","title":"Anticancer Properties of N,N-dibenzylasparagine as an Asparagine (Asp) analog, Using Colon Cancer Caco-2 Cell Line.","date":"2022","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/35901362","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28864767","id":"PMC_28864767","title":"Sequential activities of Dynein, Mud and Asp in centrosome-spindle coupling maintain centrosome number upon mitosis.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28864767","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16242000","id":"PMC_16242000","title":"CD117+ small cell lung cancer lacks the asp 816-->val point mutation in exon 17.","date":"2005","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/16242000","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30507185","id":"PMC_30507185","title":"Tuning Stacking Interactions between Asp-Arg Salt Bridges and Heterocyclic Drug Fragments.","date":"2018","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/30507185","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39042380","id":"PMC_39042380","title":"Balancing the AspC and AspA Pathways of Escherichia coli by Systematic Metabolic Engineering Strategy for High-Efficient l-Homoserine Production.","date":"2024","source":"ACS synthetic biology","url":"https://pubmed.ncbi.nlm.nih.gov/39042380","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10213871","id":"PMC_10213871","title":"Arg-gly-Asp (RGD) peptides and peptidomimetics as therapeutics: relevance for renal diseases.","date":"1999","source":"Experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/10213871","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35997444","id":"PMC_35997444","title":"Anti-Inflammatory and Mineralization Effects of an ASP/PLGA-ASP/ACP/PLLA-PLGA Composite Membrane as a Dental Pulp Capping Agent.","date":"2022","source":"Journal of functional biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/35997444","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3892239","id":"PMC_3892239","title":"Studies on toxin of Aspergillus fumigatus. XXII. Fashion of binding of Asp-hemolysin to human erythrocytes and Asp-hemolysin-binding proteins of erythrocyte membranes.","date":"1985","source":"Microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3892239","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9895333","id":"PMC_9895333","title":"Posttranslational deamidation of proteins: the case of hemoglobin J Sardegna [alpha50(CD8)His-->Asn-->Asp].","date":"1999","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9895333","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33156703","id":"PMC_33156703","title":"Australian snakebite myotoxicity (ASP-23).","date":"2020","source":"Clinical toxicology (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/33156703","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37428925","id":"PMC_37428925","title":"Horizontal gene transfer underlies the painful stings of asp caterpillars (Lepidoptera: Megalopygidae).","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37428925","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32117090","id":"PMC_32117090","title":"A Pilot Study of the Humoral Response Against the AntiSense Protein (ASP) in HIV-1-Infected Patients.","date":"2020","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32117090","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34067514","id":"PMC_34067514","title":"The HIV-1 Antisense Gene ASP: The New Kid on the Block.","date":"2021","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/34067514","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16360131","id":"PMC_16360131","title":"Arg-Gly-Asp (RGD)-containing peptides increase soluble guanylate cyclase in contractile cells.","date":"2005","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/16360131","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18356838","id":"PMC_18356838","title":"Cord blood ASP is predicted by maternal lipids and correlates with fetal birth weight.","date":"2008","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/18356838","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25910212","id":"PMC_25910212","title":"Widespread macromolecular interaction perturbations in human genetic disorders.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910212","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8252036","id":"PMC_8252036","title":"Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.","date":"1993","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8252036","citation_count":177,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18029348","id":"PMC_18029348","title":"Toward a confocal subcellular atlas of the human proteome.","date":"2007","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/18029348","citation_count":114,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8023850","id":"PMC_8023850","title":"Canavan disease: mutations among Jewish and non-Jewish patients.","date":"1994","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8023850","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3116332","id":"PMC_3116332","title":"N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy.","date":"1987","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/3116332","citation_count":95,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20201926","id":"PMC_20201926","title":"Human variation in alcohol response is influenced by variation in neuronal signaling genes.","date":"2010","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/20201926","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17194761","id":"PMC_17194761","title":"Structure of aspartoacylase, the brain enzyme impaired in Canavan disease.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17194761","citation_count":55,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12638939","id":"PMC_12638939","title":"Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.","date":"2002","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/12638939","citation_count":52,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7668285","id":"PMC_7668285","title":"The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients.","date":"1995","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7668285","citation_count":48,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9407392","id":"PMC_9407392","title":"Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.","date":"1997","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/9407392","citation_count":48,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8088831","id":"PMC_8088831","title":"Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8088831","citation_count":47,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8659549","id":"PMC_8659549","title":"Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.","date":"1996","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8659549","citation_count":46,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16935940","id":"PMC_16935940","title":"Aspartoacylase is a regulated nuclear-cytoplasmic enzyme.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/16935940","citation_count":45,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23049088","id":"PMC_23049088","title":"A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23049088","citation_count":44,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14699612","id":"PMC_14699612","title":"Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay.","date":"2004","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/14699612","citation_count":41,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16669630","id":"PMC_16669630","title":"Characterization of human aspartoacylase: the brain enzyme responsible for Canavan disease.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16669630","citation_count":35,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16437572","id":"PMC_16437572","title":"Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene.","date":"2006","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16437572","citation_count":34,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12706335","id":"PMC_12706335","title":"Purification and preliminary characterization of brain aspartoacylase.","date":"2003","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/12706335","citation_count":32,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18264947","id":"PMC_18264947","title":"Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?","date":"2008","source":"Prenatal diagnosis","url":"https://pubmed.ncbi.nlm.nih.gov/18264947","citation_count":32,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10909858","id":"PMC_10909858","title":"Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.","date":"2000","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/10909858","citation_count":31,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17391648","id":"PMC_17391648","title":"Mutational analysis of aspartoacylase: implications for Canavan disease.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17391648","citation_count":31,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49122,"output_tokens":339,"usd":0.076226},"stage2":{"model":"claude-opus-4-6","input_tokens":3483,"output_tokens":622,"usd":0.049447},"total_usd":0.387584,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62292,"output_tokens":3966,"usd":0.123183},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7087,"output_tokens":2282,"usd":0.138728}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"AAV-2 vector delivery of the ASPA gene (encoding aspartoacylase) to the brain was shown to be a viable gene therapy approach for Canavan disease, where defective ASPA leads to accumulation of N-acetyl-aspartate (NAA) and impaired myelination, establishing that restoration of ASPA enzymatic activity can address the underlying biochemical defect.\",\n      \"method\": \"Clinical gene therapy protocol with AAV-2 vector delivering ASPA to human brain; pre/post biochemical, radiological, and neurological assessments\",\n      \"journal\": \"Human gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined loss-of-function disease mechanism with functional rescue by gene delivery, single clinical study\",\n      \"pmids\": [\"12162821\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ASPA (aspartoacylase) is an enzyme that hydrolyzes N-acetyl-aspartate (NAA) in the brain; loss of functional ASPA leads to NAA accumulation in the CNS, which impairs normal myelination and results in spongiform degeneration, as established by the molecular basis of Canavan disease and demonstrated by gene therapy restoration of ASPA activity.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper, then extract discoveries only from KEEP papers.\n\n**Classification:**\n\nThe target gene ASPA encodes aspartoacylase, the brain enzyme that hydrolyzes N-acetyl-L-aspartate (NAA) to aspartate and acetate, deficiency causing Canavan disease.\n\n**KEEP papers** (about canonical ASPA/aspartoacylase):\n- Gene2pubmed curated: [9] Kaul 1993 (PMID:8252036), [12] Kaul 1994 (PMID:8023850), [13] Hagenfeldt 1987 (PMID:3116332), [16] Bitto 2006 (PMID:17194761), [17] Zeng 2002 (PMID:12638939), [18] Shaag 1995 (PMID:7668285), [19] Baslow 1997 (PMID:9407392), [20] Kaul 1994 (PMID:8088831), [21] Kaul 1996 (PMID:8659549), [22] Hershfield 2006 (PMID:16935940), [24] Feigenbaum 2004 (PMID:14699612), [25] Le Coq 2006 (PMID:16669630), [26] Janson 2006 (PMID:16437572), [27] Moore 2003 (PMID:12706335), [29] Sistermans 2000 (PMID:10909858), [30] Hershfield 2007 (PMID:17391648)\n- Retrieved [5] Janson 2002 (PMID:12162821) — about ASPA gene therapy for Canavan disease\n\n**EXCLUDE** — all others are alias collisions or unrelated genes (ASP = Drosophila abnormal spindle, ASP = acylation stimulating protein/C3adesArg, ASP = HIV antisense protein, ASP = Aspergillus proteins, ASP = various other acronyms, RGD peptides, tRNA-Asp, bacteriorhodopsin Asp residues, etc.)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"Aspartoacylase (ASPA) deficiency was identified as the cause of elevated N-acetylaspartate (NAA) excretion and leukodystrophy; fibroblasts from the patient showed absent aspartoacylase activity, establishing that ASPA catalyzes NAA hydrolysis in brain and that its deficiency leads to dysmyelination.\",\n      \"method\": \"Enzymatic activity assay in patient fibroblasts; CSF/plasma NAA ratio measurement\",\n      \"journal\": \"Journal of inherited metabolic disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct enzyme activity measurement in patient cells linking ASPA deficiency to NAA accumulation and disease, foundational finding replicated across subsequent studies\",\n      \"pmids\": [\"3116332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The human aspartoacylase (ASPA) cDNA was cloned and shown to express aspartoacylase activity in bacteria. A common missense mutation Glu285Ala (854A→C) was identified in 85% of Canavan alleles and predicted to disrupt a catalytic Ser/His/Glu triad, establishing that the catalytic domain involves these residues.\",\n      \"method\": \"cDNA cloning, heterologous expression in bacteria, mutation analysis of patient alleles\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct heterologous expression demonstrating enzymatic activity; foundational cloning paper replicated in many subsequent studies\",\n      \"pmids\": [\"8252036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The human ASPA gene was mapped to chromosome 17p13-ter, spans 29 kb with 6 exons and 5 introns, and its coding sequences cross-hybridize with genomic DNA from multiple vertebrates, indicating evolutionary conservation of aspartoacylase.\",\n      \"method\": \"Genomic cloning, Southern blot analysis of somatic cell hybrid lines, fluorescence in situ hybridization (FISH)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal localization by FISH and hybrid cell lines; replicated and consistent with subsequent studies\",\n      \"pmids\": [\"8088831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Three point mutations in ASPA (693C→A causing Tyr231→stop, 854A→C causing Glu285→Ala, 914C→A causing Ala305→Glu) were characterized by in vitro expression: Tyr231→stop and Ala305→Glu cause complete loss of ASPA activity, while Glu285→Ala retains ~2.5% activity. A splice-site mutation (433−2 A→G) causing exon 3 skipping and frameshift was also identified.\",\n      \"method\": \"In vitro expression of mutant cDNAs in cell-free or cellular systems, enzyme activity assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro expression with quantitative activity assay; multiple mutations characterized; widely replicated\",\n      \"pmids\": [\"8023850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Nine ASPA mutations in non-Jewish Canavan patients were identified; A305E is the predominant pan-European mutation (39.5% of alleles), and in vitro expression studies confirmed these mutations cause loss of aspartoacylase enzymatic activity.\",\n      \"method\": \"Mutation analysis of ASPA gene, in vitro expression, enzyme activity assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro expression with activity assays confirming loss-of-function; broad ethnic characterization\",\n      \"pmids\": [\"7668285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Eight novel ASPA missense and deletion mutations in non-Jewish Canavan patients (including I16T, G27R, D114E, G123E, C152Y, R168C, 32ΔT, 876ΔAGAA) were introduced into wild-type cDNA by PCR mutagenesis; in vitro expression in COS-7 cells confirmed all lead to ASPA enzyme deficiency.\",\n      \"method\": \"Site-directed mutagenesis, transient expression in COS-7 cells, enzyme activity assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct mutagenesis and expression with quantitative activity measurement\",\n      \"pmids\": [\"8659549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Analysis of NAA biochemistry in Canavan disease established that ASPA deficiency creates a daily aspartate deficit in the CNS at least six times the static free-aspartate level, eliminates the intercompartmental NAA-to-aspartate cycling that normally supplies acetyl groups for myelin lipid synthesis, and results in up to 50-fold reduction in the intercompartmental NAA gradient.\",\n      \"method\": \"Biochemical flux analysis of NAA cycle across multiple vertebrate species and Canavan disease metabolite data\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative metabolic modeling grounded in multi-species biochemical data; single lab but uses multiple data sources\",\n      \"pmids\": [\"9407392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Fourteen novel ASPA mutations in non-Jewish patients were identified; in vitro expression in COS-7 cells and patient fibroblast assays confirmed enzyme deficiency. Notably, E24G disrupts the first esterase catalytic domain consensus sequence, reinforcing the importance of Glu24 for catalysis; IVS1−2A→T caused retention of 40 nt of intron 1.\",\n      \"method\": \"ASPA gene sequencing, transient expression in COS-7 cells, enzyme activity assay in fibroblasts\",\n      \"journal\": \"Journal of inherited metabolic disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct expression and activity assay confirming pathogenicity; multiple mutations across diverse patients\",\n      \"pmids\": [\"12638939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"AAV-2 vector-mediated delivery of the ASPA gene directly to human brain in Canavan disease patients demonstrated the first clinical use of AAV in the human brain, providing proof-of-concept that ASPA can be delivered in vivo to correct the enzymatic deficiency.\",\n      \"method\": \"Clinical gene therapy protocol; neurosurgical AAV-2 delivery; pre/post neurological, biochemical, and radiological assessment\",\n      \"journal\": \"Human gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — first-in-human interventional study; single trial, pilot scale\",\n      \"pmids\": [\"12162821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Murine and human aspartoacylase were cloned and expressed in E. coli. Kinetic parameters showed relaxed substrate specificity for the acyl group. The clinically relevant E285A mutant has markedly reduced stability and barely detectable activity, while E285D retains ~one-fifth normal activity, establishing that Glu285 is critical for catalysis.\",\n      \"method\": \"Recombinant expression in E. coli, enzyme-coupled continuous spectrophotometric kinetic assay, site-directed mutagenesis\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with quantitative kinetics and mutagenesis\",\n      \"pmids\": [\"12706335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structures of human (2.8 Å) and rat (1.8 Å) aspartoacylase revealed that the N-terminal domain adopts a zinc-dependent hydrolase fold related to carboxypeptidase A, with a catalytic zinc ion coordinated by specific residues. The C-terminal domain (~100 residues) forms a globular domain that wraps around the N-terminal domain and occludes the active-site channel from polypeptide substrates. Residues 158–164 may gate substrate access. The catalytic mechanism is proposed to be analogous to carboxypeptidases.\",\n      \"method\": \"X-ray crystallography of recombinant human and rat ASPA; structural comparison with carboxypeptidase A\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional interpretation; two species solved independently\",\n      \"pmids\": [\"17194761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Human aspartoacylase expressed in Pichia pastoris is 150-fold more active and significantly more stable than the E. coli-expressed form. Mass spectrometry showed the enzyme contains a glycosylation modification; deglycosylation or mutation at the glycosylation site decreases stability and catalytic activity. Each subunit contains one zinc atom; chelation causes reversible loss of activity, establishing ASPA as a zinc metalloenzyme.\",\n      \"method\": \"Pichia pastoris expression, mass spectrometry of glycan, zinc chelation studies, kinetic assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution, zinc chelation reversal, glycosylation mutagenesis; multiple orthogonal methods in one study\",\n      \"pmids\": [\"16669630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Aspartoacylase localizes not only to the cytoplasm but also to the nucleus of rat brain cells, kidney, and cultured oligodendrocytes. Subcellular fractionation showed low but detectable NAA-hydrolyzing activity in nuclear fractions. Size-exclusion chromatography showed ASPA is an active monomer in both compartments (not a dimer). A GFP-hASPA fusion protein exceeding the nuclear pore size limit also showed nuclear distribution, suggesting active or facilitated nuclear import.\",\n      \"method\": \"Immunohistochemistry, subcellular fractionation with enzyme activity assay, size-exclusion chromatography, GFP fusion protein expression in COS-7 cells\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization methods with functional (enzymatic) validation in both compartments\",\n      \"pmids\": [\"16935940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Homology modeling of ASPA based on carboxypeptidase A guided site-directed mutagenesis. Mutations of putative zinc-binding residues (H21G, E24D/G, H116G), the proposed proton donor (E178A), substrate carboxyl-binding residue (R71N), and transition-state stabilizing residue (R63N) all yield wild-type ASPA protein levels but undetectable activity. Double-swap mutants (H21E/E24H and E24H/H116E) also abolish activity. Cys124 and Cys152 alanine substitutions reduce both protein and activity levels, suggesting a disulfide bond. These results confirm ASPA belongs to the carboxypeptidase A family and define key catalytic residues.\",\n      \"method\": \"Homology modeling, site-directed mutagenesis, transient expression, Western blotting, enzyme activity assay\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis of multiple active-site residues with quantitative activity and protein-level controls\",\n      \"pmids\": [\"17391648\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ASPA (aspartoacylase) is a zinc metalloenzyme with a carboxypeptidase A-like N-terminal catalytic domain and a C-terminal domain that gates substrate access; it hydrolyzes N-acetyl-L-aspartate (NAA) to aspartate and acetate in the brain, is glycosylated (glycosylation required for stability and activity), functions as an active monomer in both cytoplasmic and nuclear compartments of oligodendrocytes, and loss-of-function mutations abolishing activity at zinc-coordinating (H21, E24, H116), proton-donor (E178), or substrate-binding (R63, R71) residues cause Canavan disease through NAA accumulation and failure of acetyl-group supply for myelin lipid synthesis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ASPA encodes aspartoacylase, an enzyme that hydrolyzes N-acetyl-aspartate (NAA) in the brain; loss of ASPA function causes accumulation of NAA in the central nervous system, leading to impaired myelination and spongiform degeneration characteristic of Canavan disease, as demonstrated by biochemical correction following AAV-mediated ASPA gene delivery [PMID:12162821].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that AAV-mediated delivery of the ASPA gene to the human brain could restore aspartoacylase activity established that the enzyme's absence is the direct cause of NAA accumulation and the resulting myelination defect in Canavan disease.\",\n      \"evidence\": \"Clinical gene therapy trial using AAV-2 vector delivering ASPA to human brain with pre/post biochemical, radiological, and neurological assessments\",\n      \"pmids\": [\"12162821\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single clinical study without controlled comparison; long-term efficacy and durability of correction not established\",\n        \"Precise mechanism by which NAA accumulation impairs myelination remains unresolved\",\n        \"Optimal vector, dose, and delivery route for full biochemical normalization not determined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for ASPA substrate specificity and catalytic mechanism, the cell-type-specific requirements for ASPA expression in the CNS, and the downstream pathways linking NAA accumulation to oligodendrocyte dysfunction remain incompletely characterized in the primary literature captured here.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural or enzymological studies captured defining the catalytic mechanism\",\n        \"Cell-type-specific expression requirements in the CNS not resolved\",\n        \"Relationship between NAA levels and oligodendrocyte/myelin homeostasis not mechanistically defined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"ASPA (aspartoacylase) is a zinc metalloenzyme that hydrolyzes N-acetyl-L-aspartate (NAA) to aspartate and acetate, providing acetyl groups essential for myelin lipid synthesis in the central nervous system [PMID:3116332, PMID:9407392]. Structurally, ASPA comprises an N-terminal catalytic domain with a carboxypeptidase A-like zinc-dependent hydrolase fold and a C-terminal domain that gates substrate access to the active site; catalysis depends on zinc-coordinating residues (H21, E24, H116), a proton donor (E178), and substrate-binding arginines (R63, R71), and glycosylation is required for full stability and activity [PMID:17194761, PMID:17391648, PMID:16669630]. ASPA functions as an active monomer in both the cytoplasm and nucleus of oligodendrocytes, with evidence for active or facilitated nuclear import [PMID:16935940]. Loss-of-function mutations in ASPA cause Canavan disease, an autosomal recessive leukodystrophy characterized by NAA accumulation and dysmyelination [PMID:3116332, PMID:8252036].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Identifying the enzymatic basis of Canavan disease established that ASPA catalyzes NAA hydrolysis and that its deficiency leads to NAA accumulation and dysmyelination, framing the gene's central biological role.\",\n      \"evidence\": \"Enzymatic activity assay in patient fibroblasts showing absent aspartoacylase activity\",\n      \"pmids\": [\"3116332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity (gene/cDNA) of ASPA not yet determined\", \"Catalytic mechanism unknown\", \"Tissue and subcellular distribution of activity uncharacterized\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Cloning the ASPA cDNA and demonstrating recombinant enzymatic activity enabled molecular characterization of disease-causing mutations and first implicated specific residues (including E285) in catalysis.\",\n      \"evidence\": \"cDNA cloning with heterologous expression in bacteria; identification of E285A as the predominant Ashkenazi Jewish mutation\",\n      \"pmids\": [\"8252036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic mechanism and active-site architecture unresolved\", \"Three-dimensional structure unavailable\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Systematic in vitro expression of patient-derived mutations (Y231X, E285A, A305E) quantified residual activity and demonstrated allelic heterogeneity, while genomic characterization mapped ASPA to 17p13-ter across six exons.\",\n      \"evidence\": \"In vitro mutagenesis and expression with quantitative enzyme assays; FISH and somatic cell hybrid mapping\",\n      \"pmids\": [\"8023850\", \"8088831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure-function relationships for most residues unknown\", \"No structural data to explain why specific mutations abolish activity\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Expanding the mutation spectrum across diverse ethnic backgrounds (including I16T, G27R, D114E, G123E, C152Y, R168C) and confirming loss of function by COS-7 expression demonstrated that pathogenic variants are distributed across the entire protein, not confined to a single domain.\",\n      \"evidence\": \"Site-directed mutagenesis with transient expression in COS-7 cells and enzyme activity assay\",\n      \"pmids\": [\"8659549\", \"7668285\", \"12638939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Active-site residue identity still inferred from sequence homology rather than structure\", \"Role of glycosylation and metal cofactors unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Metabolic flux analysis revealed that ASPA deficiency eliminates intercompartmental NAA-to-aspartate cycling, creating a large daily aspartate deficit and depriving oligodendrocytes of acetyl groups for myelin lipid synthesis — connecting the enzymatic defect to the dysmyelination phenotype.\",\n      \"evidence\": \"Quantitative biochemical flux modeling using multi-species NAA metabolite data and Canavan disease metabolite profiles\",\n      \"pmids\": [\"9407392\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Flux estimates rely on modeling rather than direct in vivo tracing\", \"Relative contribution of acetyl-group deficit vs. NAA toxicity to pathology not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Recombinant kinetic characterization showed relaxed acyl-group specificity and confirmed that E285A drastically reduces both stability and activity while the conservative E285D retains partial function, pinpointing E285 as catalytically essential.\",\n      \"evidence\": \"Recombinant E. coli expression with continuous spectrophotometric kinetic assays and site-directed mutagenesis\",\n      \"pmids\": [\"12706335\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of E285 contribution awaited crystallographic data\", \"Substrate-binding mode unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Crystal structures of human and rat ASPA revealed a two-domain architecture — an N-terminal carboxypeptidase A-like zinc hydrolase domain and a C-terminal domain that occludes the active site from polypeptide substrates — explaining the enzyme's specificity for small-molecule NAA and identifying the zinc coordination sphere and a putative substrate-gating loop (residues 158–164).\",\n      \"evidence\": \"X-ray crystallography at 2.8 Å (human) and 1.8 Å (rat) resolution\",\n      \"pmids\": [\"17194761\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No substrate- or product-bound co-crystal structure\", \"Gating dynamics of residues 158–164 not experimentally validated\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that ASPA is glycosylated, contains one zinc per subunit with chelation-reversible activity loss, and functions as a monomer in both cytoplasm and nucleus of oligodendrocytes established key biochemical properties and an unexpected nuclear localization with enzymatic activity.\",\n      \"evidence\": \"Pichia pastoris expression with mass spectrometry (glycan), zinc chelation/reconstitution, subcellular fractionation with activity assay, size-exclusion chromatography, GFP-fusion localization in COS-7 cells\",\n      \"pmids\": [\"16669630\", \"16935940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear import mechanism (signal sequence or carrier) not identified\", \"Biological role of nuclear NAA hydrolysis unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Comprehensive site-directed mutagenesis of predicted active-site residues (H21, E24, H116 for zinc coordination; E178 as proton donor; R63, R71 for substrate binding; C124/C152 for disulfide stability) definitively assigned catalytic roles, confirming ASPA belongs to the carboxypeptidase A metalloenzyme family.\",\n      \"evidence\": \"Homology model-guided mutagenesis with transient expression, Western blot protein-level controls, and quantitative enzyme activity assay\",\n      \"pmids\": [\"17391648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No substrate-bound crystal structure to confirm predicted binding geometry\", \"Transition-state stabilization by R63 inferred from analogy, not directly visualized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The biological function of nuclear ASPA, the structural basis of substrate gating by the C-terminal domain, and the relative contributions of NAA toxicity versus acetyl-group deprivation to Canavan disease pathogenesis remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No substrate- or transition-state-bound co-crystal structure available\", \"Nuclear import mechanism and nuclear NAA metabolic function uncharacterized\", \"In vivo metabolic tracing to distinguish NAA toxicity from acetyl-group deficit not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 9, 10, 11, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 6, 9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```"}